Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring

American Journal of Therapeutics

Volumn 21, Issue 2, 2014, Pages 73-80

  Bjørn, Anne Mette Bay ^a   Ehrenstein, Vera ^a   Hundborg, Heidi Holmager ^a   Nohr, Ellen Aagaard ^b   Sørensen, Henrik Toft ^a   Nørgaard, Mette ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Congenital malformation; Corticosteroids; Epidemiology; Oral clefts; Pregnancy

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; ASTHMA; CLEFT LIP; CLEFT PALATE; CONCEPTION; CONGENITAL MALFORMATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DENMARK; FEMALE; FIRST TRIMESTER PREGNANCY; GROUPS BY AGE; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL DIABETES MELLITUS; MATERNAL SMOKING; MEDICAL HISTORY; MOUTH MALFORMATION; ORAL CLEFT; PRESCRIPTION; PREVALENCE; PRIMIPARA; PRIORITY JOURNAL; PROGENY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; THIRD TRIMESTER PREGNANCY;

ABNORMALITIES, DRUG-INDUCED; CLEFT LIP; CLEFT PALATE; DENMARK; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREVALENCE; REGISTRIES; RISK;

EID: 84896392074     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3182491e02     Document Type: Article

References (43)

1. Carmichael SL, Shaw GM, Ma C, et al. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007; 197:585. e1-e7.
2. McGee DC. Steroid use during pregnancy. J Perinat Neonatal Nurs. 2002;16:26-39.
3. Briggs G, Freeman R, Yaffe S. Drugs in Pregnancy and Lactation. 7th ed. Philidelphia, PA: Lippincott Williams & Wilkins; 2005.
4. Gitau R, Cameron A, Fisk NM, et al. Fetal exposure to maternal cortisol. Lancet. 1998;352:707-708.
5. Hübner M, Hochhaus G, Derendorf H. Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids. Immunol Allergy Clin North Am. 2005;25:469-488.
6. Pacheco LD, Ghulmiyyah LM, Snodgrass WR, et al. Pharmacokinetics of corticosteroids during pregnancy. Am J Perinatol. 2007;24:79-82.
7. Fraser FC, Fainstat TD. The production of congenital defects in the offspring of pregnant mice treated with cortisone: a progress report. Pediatrics. 1951;8:527-533.
8. Rowland JM, Hendrickx AG. Corticosteroid teratogenicity. Adv Vet Sci Comp Med. 1983;27:99-128.
9. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet. 1999;86:242-244.
10. Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology. 1997;56:335-340.
11. Källén B, Olausson PO. Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants. Eur J Clin Pharmacol. 2007;63:383-388.
12. Pradat P, Robert-Gnansia E, Di Tanna GL, et al. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol. 2003;67:968-970.
13. Rodríguez-Pinilla E, Martínez-Frías M. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology. 1998;58:2-5.
14. Alexander S, Dodds L, Armson BA. Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol. 1998;92:435-440.
15. Gur C, Diav-Citrin O, Shechtman S, et al. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol. 2004;18: 93-101.
16. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62:385-392.
17. Schatz M, Zeiger RS, Harden K, et al. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol. 1997;100:301-306.
18. Pedersen C, Gotzsche H, Moller J, et al. The Danish civil registration system. A cohort of eight million persons. Dan Med Bull. 2006;53:441-449.
19. Kristensen J, Langhoff-Roos J, Theil Skovgaard L, et al. Validation of the Danish birth registration. J Clin Epidemiol. 1996;49:893-897.
20. Jørgensen FS. Organization of obstetric ultrasound in Denmark 2000-with description of the development since 1990. Dan Med Bull. 2003;165:4404-4409.
21. National Board of Health. Available at: http://www.sst. dk/Indberetning%20og%20statistik/Sundhedsstyrelsens% 20registre/ Foedselsregister.aspx. Accessed April 26, 2011.
22. Yang T, Walker MC, Krewski D, et al. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population. Pharmacoepidemiol Drug Saf. 2008;17:270-277.
23. Ehrenstein V, Antonsen S, Pedersen L. Existing data sources for clinical epidemiology: Aarhus university prescription database. Clin Epidemiol. 2010;2:273-279.
24. Ministry of Health and Prevention. Report: Health Care in Denmark, 2008. Available at: http://www.sum. dk/Aktuelt/Publikationer/Publikationer/UK- Healthcare-in-DK.aspx. Accessed January 10, 2011.
25. Andersen TF, Madsen M, Jørgensen J, et al. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
26. Weinberg CR, Wilcox AJ. Methodologic issues in reproductive epidemiology. In: Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology. 3rd ed. Philidelphia, PA: Lippincott Williams & Wilkins; 2008:620-640.
27. Larsen H, Nielsen GL, Bendsen J, et al. Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries. Scand J Public Health. 2003;31:12-16.
28. Bille C, Olsen J, Vach W, et al. Oral clefts and life style factors-a case-cohort study based on prospective Danish data. Eur J Epidemiol. 2007;22:173-181.
29. Blais L, Kettani FZ, Elftouh N, et al. Effect of maternal asthma on the risk of specific congenital malformations: a population-based cohort study. Birth Defects Res A Clin Mol Teratol. 2010;88:216-222.
30. Nørgaard M, Larsson H, Pedersen L, et al. Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J. Intern Med. 2010;268: 329-337.
31. Nielsen GL, Nørgard B, Puho E, et al. Risk of specific congenital abnormalities in offspring of women with diabetes. Diabet Med. 2005;22:693-696.
32. Clore J, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009;15:469-474.
33. Källén B, Rydhstroem H, Åberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol. 1999;93:392-395.
34. Källén B. Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft Palate Craniofac J. 2003;40:624-628.
35. Ehrenstein V, Sørensen HT, Bakketeig LS, et al. Medical databases in studies of drug teratogenicity: methodological issues. Clin Epidemiol. 2010;2:37-43.
36. Rockenbauer M, Olsen J, Czeizel AE, et al. Recall bias in a case control surveillance system on the use of medicine during pregnancy. Epidemiology. 2001;12:461-466.
37. Mitchell A, Cottler L, Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol. 1986;123:670-676.
38. Løkkegaard EL, Johnsen SP, Heitmann BL, et al. The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand. 2004;83:476-481.
39. The Danish Medicine Agency. Available at: http//www.medicin.dk. Accessed July 12, 2011.
40. DeRoo LA, Wilcox AJ, Drevon CA, et al. Firsttrimester maternal alcohol consumption and the risk of infant oral clefts in Norway: a populationbased case-control study. Am J Epidemiol. 2008;168: 638-646.
41. Olsen J, Melbye M, Olsen SF, et al. The Danish National Birth Cohort-its background, structure and aim. Scand J Public Health. 2001;29:300-307.
42. Jensen AØ, Nielsen GL, Ehrenstein V. Validity of asthma diagnoses in the Danish National Registry of Patients, including an assessment of impact of misclassification on risk estimates in an actual dataset. Clin Epidemiol. 2010;2:67-72.
43. Mitchell A. Studies of drug-induced birth defects. In: Strom B, ed. Pharmacoepidemiology. 4th ed. West Sussex, United Kingdom: John Wiley and Sons Ltd; 2005: 501-514.